News
WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications. Read More ⇒
THE LATEST
Transforming Care for COVID-19 with NuvOx Pharma
NuvOx Pharma has the potential to transform COVID-19 care with its NanO2™ emulsion for oxygen delivery. With approval from Health Canada to proceed with a Phase IIa clinical trial, NuvOx Pharma is making strong headway in COVID-19 innovations.
COVID-19 Open Grant List
With the world singularly united in efforts to solve the challenges presented by COVID-19, there is an international call for research and innovations to fight the pandemic. Hunniwell Lake Ventures has compiled a list of active COVID-19 grants, globally sourced from governments and organizations, seeking a variety of solutions and reliefs.
COVID-19 Start-up List
The uncertainty and chaos created by the COVID-19 pandemic have led to the international need for innovations to fight against the virus. Hunniwell Lake Ventures has identified numerous start-up companies across the globe that have pivoted to COVID-19 based solutions and reliefs and compiled them into a list which gives a short description and has been sorted by location and focus.
Hunniwell at the Spring 2020 F50 Global Capital Summit
Hunniwell Lake Ventures (HLV) is pleased to sponsor this year’s Spring F50 Global Capital Summit, June 16-17, 2020. Watch HLV partners give talks, host live roundtables, speak on panels and judge startups.
Four Industry Veterans Join Hunniwell
Hunniwell Lake Ventures is pleased to gain the strategic counsel of these talented, highly experienced and successful professionals - David Schechter, David Cao, John Ashley and Matt Otten - as they help us achieve our mission towards Intelligent Surgery.
Hunniwell Shares Insights with UCLA BioDesign Program
Hunniwell Lake Ventures Managing Partner Daniel Teo shares keen advice with the inaugural class of 2020 Fellows in the UCLA BioDesign Program in his presentation titled "Tales from the Other Side."
Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Its mission is to make surgery safer, more accessible and less invasive by investing in innovations that help surgeons visualize the operative field better, employ surgical tools using improved and advanced technologies to treat the patient, and ensure their speedy recovery through the best wound closure and tissue healing technologies available.
